Gilead Sciences, Inc. (GILD) is trading at $150.56 up 0.30% over the past 24 hours. Its Galaxy Score is 59.8, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 32.4K engagements and 129 posts with 98% positive social sentiment.
LunarCrush tracks live social sentiment, mentions, news, and influencer activity for Gilead Sciences, Inc. (GILD) across X, Reddit, StockTwits, YouTube, and news. Follow how conversation around GILD is shifting alongside price, Galaxy Score, social dominance, market cap, and 24-hour engagements and mentions. This is the social intelligence snapshot for Gilead Sciences, Inc. (GILD): who is talking, how they feel, and how loud the conversation is right now. Numbers update throughout the day as new posts, news headlines, and creator activity land. Read this page as the Gilead Sciences, Inc. (GILD) briefing: live market context, social volume, and the tone of the conversation in one snapshot.
AI summary: Gilead Sciences, Inc. (GILD) is a U.S.-listed biopharmaceutical company focused on HIV treatments, antivirals, and oncology drugs. Positive reception of new HIV treatments and global access expansion drive Gilead's stock price, while insider selling and payer pressure cap gains.